These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38219270)

  • 1. Prevalence of Psychotropic Medication Use and Psychotropic Polypharmacy in Autistic Adults With or Without Intellectual Disability.
    Yoshida K; Lunsky Y; Müller DJ; Desarkar P
    J Autism Dev Disord; 2024 Jan; ():. PubMed ID: 38219270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, patterns and factors associated with psychotropic use in older adults with intellectual disabilities in Ireland.
    O'Dwyer M; Peklar J; Mulryan N; McCallion P; McCarron M; Henman MC
    J Intellect Disabil Res; 2017 Oct; 61(10):969-983. PubMed ID: 28639298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimorbidity and psychotropic polypharmacy among participants with autism spectrum disorder with intellectual disability.
    Espadas C; Ballester P; Londoño AC; Almenara S; Aguilar V; Belda C; Pérez E; Peiró AM
    Psychiatry Res; 2020 Oct; 292():113321. PubMed ID: 32738553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polypharmacy and psychotropic polypharmacy in adults with intellectual disability: a cross-sectional total population study.
    McMahon M; Hatton C; Bowring DL
    J Intellect Disabil Res; 2020 Nov; 64(11):834-851. PubMed ID: 32902029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
    Deb S; Unwin G; Deb T
    J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of psychotropic medication use and association with challenging behaviour in adults with an intellectual disability. A total population study.
    Bowring DL; Totsika V; Hastings RP; Toogood S; McMahon M
    J Intellect Disabil Res; 2017 Jun; 61(6):604-617. PubMed ID: 28090687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of Psychotropic Polypharmacy Among Outpatients With Psychiatric Disorders and Intellectual Disability.
    Lunsky Y; Modi M
    Psychiatr Serv; 2018 Feb; 69(2):242-246. PubMed ID: 29089006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of Mental Health Service Use During the Transition to Adulthood Among Autistic Adolescents and Young Adults.
    Davis SA; Annis IE; Hughes PM; DeJong NA; Christian RB; Ruble LA; Thomas KC
    Autism Adulthood; 2023 Dec; 5(4):366-373. PubMed ID: 38116058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychiatric Comorbidities and Psychotropic Medication Use in Autism: A Matched Cohort Study with ADHD and General Population Comparator Groups in the United Kingdom.
    Houghton R; Liu C; Bolognani F
    Autism Res; 2018 Dec; 11(12):1690-1700. PubMed ID: 30380202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autism spectrum disorder in older adults with intellectual disability: a scoping review.
    Maguire E; Mulryan N; Sheerin F; McCallion P; McCarron M
    Ir J Psychol Med; 2022 Sep; 39(3):287-300. PubMed ID: 34612183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychotropic medication use for adults and older adults with intellectual disability; selective review, recommendations and future directions.
    Deutsch SI; Burket JA
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110017. PubMed ID: 32544599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication burden and frailty in older adults with intellectual disability: An observational cross-sectional study.
    O'Connell J; Henman MC; McMahon N; Burke É; McCallion P; McCarron M; O'Dwyer M
    Pharmacoepidemiol Drug Saf; 2020 Apr; 29(4):482-492. PubMed ID: 32134549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of psychotropic medications in adults with intellectual disability: a scoping review.
    Costello A; Hudson E; Morrissey S; Sharma D; Kelly D; Doody O
    Ann Med; 2022 Dec; 54(1):2486-2499. PubMed ID: 36120887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central nervous system medication use in older adults with intellectual disability: Results from the successful ageing in intellectual disability study.
    Chitty KM; Evans E; Torr JJ; Iacono T; Brodaty H; Sachdev P; Trollor JN
    Aust N Z J Psychiatry; 2016 Apr; 50(4):352-62. PubMed ID: 26019276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychotropic medication and psychotherapeutic treatment of adults with intellectual disabilities (PROMPT-ID): a cross-sectional, epidemiological study in Saxony, Germany.
    Koch A; Dobrindt J; Schützwohl M
    BMJ Open; 2018 Dec; 8(12):e025947. PubMed ID: 30573492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological management of behavioral and psychiatric symptoms in older adults with intellectual disability.
    Eady N; Courtenay K; Strydom A
    Drugs Aging; 2015 Feb; 32(2):95-102. PubMed ID: 25573538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychopathology in adults with autism and intellectual disability.
    Tsakanikos E; Costello H; Holt G; Bouras N; Sturmey P; Newton T
    J Autism Dev Disord; 2006 Nov; 36(8):1123-9. PubMed ID: 16855878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of psychotropic medication and factors associated with antipsychotic treatment in adults with intellectual disabilities: a cross-sectional, epidemiological study in Germany.
    Koch AD; Dobrindt J; Schützwohl M
    J Intellect Disabil Res; 2021 Feb; 65(2):186-198. PubMed ID: 33393123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adults with Intellectual Disability and Autism Spectrum Disorder: What Is the Evidence around the Use of Polypharmacy.
    McCarthy JM; Chaplin E
    Int J Environ Res Public Health; 2022 Nov; 19(23):. PubMed ID: 36498043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychotropic Polypharmacy Among Children and Youth Receiving Medicaid, 2012-2015.
    Lohr WD; Creel L; Feygin Y; Stevenson M; Smith MJ; Myers J; Woods C; Liu G; Davis DW
    J Manag Care Spec Pharm; 2018 Aug; 24(8):736-744. PubMed ID: 30058983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.